Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
Steve Boudewijns, Kalijn F. Bol, Gerty Schreibelt, Harm Westdorp, Johannes C. Textor, Michelle M. van Rossum, Nicole M. Scharenborg, Annemiek J. de Boer, Mandy W.M.M. van de Rakt, Jeanne M. Pots, Tom G.M. van Oorschot, Tjitske Duiveman-de Boer, Michel A. Olde Nordkamp, Wilmy S.E.C. van Meeteren, Winette T.A. van der Graaf, Johannes J. Bonenkamp, Johannes H.W. de Wilt, Erik H.J.G. Aarntzen, Cornelis J.A. Punt, Winald R. GerritsenCarl G. Figdor, I. Jolanda M. de Vries
Dive into the research topics of 'Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients'. Together they form a unique fingerprint.